🔎 Trials Near Me

홈 › 미만성 거대 B세포 림프종 › 미시간

미시간의 미만성 거대 B세포 림프종 임상 시험

미만성 거대 B세포 림프종 관련 연구 15개가 미시간 내 여러 지역에서 참여자를 모집하고 있습니다.

미시간의 도시

공식 연구 텍스트(영어)

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

  • OSF Saint Francis Hospital and Medical Group, Escanaba
  • Schoolcraft Memorial Hospital, Manistique
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06649812

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  • Karmanos Cancer Institute, Detroit
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05006716

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

  • Corewell Health ( Site 0162), Grand Rapids
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05139017

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor ( Site 9545), Ann Arbor
  • Karmanos Cancer Institute ( Site 0174), Detroit
  • Corewell Health ( Site 0130), Grand Rapids
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06717347

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  • Henry Ford Health System, Detroit
  • Cancer and Hematology Centers of Western Michigan, Grand Rapids
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06091865

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • University of Michigan Comprehensive Cancer Center, Ann Arbor
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07101328

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Corewell Health ( Site 1001), Grand Rapids
피험자 모집 중1/2상
6 Months – 25 Years · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06395103

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

  • University of Michigan, Ann Arbor
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07195916

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

  • Corewell Health, Grand Rapids
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT06806033

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Corewell Health, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT05826535

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

  • START Midwest, Grand Rapids
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT07424833

DALY II USA/ MB-CART2019.1 for DLBCL

  • University of Michigan, Ann Arbor
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 13. 업데이트됨 · NCT04792489

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

  • Karmanos Cancer Center (Wayne State University), Detroit
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 10. 업데이트됨 · NCT05852717

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

  • Bronson Battle Creek, Battle Creek
  • Wayne State University/Karmanos Cancer Institute, Detroit
  • Henry Ford Hospital, Detroit
  • 외 13개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 2. 2. 업데이트됨 · NCT05633615

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
  • Trinity Health Medical Center - Brighton, Brighton
  • 외 12개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2025. 10. 20. 업데이트됨 · NCT05890352

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.